Business Description
Xencor is a Pasadena-based biopharmaceutical company that designs and develops advanced antibody therapies to treat cancer and autoimmune diseases. Its technology platform has produced a broad pipeline of drug candidates targeting conditions ranging from various cancers, including prostate, ovarian, and kidney cancers, to autoimmune and inflammatory diseases such as Crohn's disease, rheumatoid arthritis, and lupus. Several of its medicines are already approved and in use, while many others are currently being tested in clinical trials in partnership with major pharmaceutical companies worldwide.
